Impact of Recipient HLA-C in Liver Transplant: A Protective Effect of HLA-Cw*07 on Acute Rejection

Human Immunology

Volumn 68, Issue 1, 2007, Pages 51-58

  Moya Quiles, Maria R ^a   Alvarez, Ruben ^b   Miras, Manuel ^a   Gomez Mateo, Jorge ^a   Lopez Alvarez, Maria R ^a   Marin Moreno, Isabel ^a   Martínez Barba, Enrique ^a   Sanchez Mozo, Maria P S ^b   Gomez, Manuel ^b   Arnal, Francisco ^b   Sanchez Bueno, Francisco ^a   Marin, Luis A ^a   Garcia Alonso, Ana M ^a   Minguela, Alfredo ^a   Muro, Manuel ^a   Parrilla, Pascual ^a   Alonso, Clara ^b   Álvarez López, Maria R ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b University Hospital Juan Canalejo   (Spain)

Author keywords

acute rejection; Asn80; HLA C; liver transplant; Lys80

Indexed keywords

ASPARAGINE; AZATHIOPRINE; CD3 ANTIBODY; CYCLOSPORIN A; EPITOPE; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; LYSINE; METHYLPREDNISOLONE;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPAIN;

ACUTE DISEASE; ALLELES; FEMALE; GRAFT REJECTION; HLA-C ANTIGENS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 33846002397     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.10.009     Document Type: Article

References (42)

1. Nikaein A., Backman L., Jennings L., Levy M., Goldstein R., Gonwa T., Stone M., and Klintmalm G. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation 58 (1994) 786
2. Donaldson P., Underhill J., Doherty D., Hayllar K., Calne R., Tan K.C., O'Grady J., Wight D., Portmann B., and Williams R. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect". Hepatology 17 (1993) 1008
3. Ontanon J., Muro M., Garcia-Alonso A.M., Minguela A., Torio A., Bermejo J., Pons J.A., Campos M., and Alvarez-Lopez M.R. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients. Hum Immunol 65 (1998) 1047
4. Manez R., White L.T., Linden P., Kusne S., Martin M., Kramer D., Demetris A.J., Van Thiel D.H., Starzl T.E., and Duquesnoy R.J. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after transplantation. Transplantation 55 (1993) 1067
5. Markus B.H., Duquesnoy R.J., Blaheta R.A., Scholz M., and Encke A. Role of HLA antigens in liver transplantation with special reference to cellular immune reactions. Langenbecks Arc Surg 383 (1998) 87
6. Markus B.H., Fung J.J., Zeevi A., Starzl T.E., Demetris A.J., and Duquesnoy R.J. Analysis of T lymphocytes infiltrating human hepatic allografts. Transplant Proc 19 (1987) 2470
7. Warle M.C., Metselaar H.J., Hop W.C., and Tilanus H.W. Cytokine gene polymorphisms and acute liver graft rejection: a meta-analysis. Liver Transpl 11 (2005) 19
8. Marin L.A., Moya-Quiles M.R., Miras M., Muro M., Minguela A., Bermejo J., Ramirez P., Garcia-Alonso A.M., Parrilla P., and Alvarez-Lopez M.R. Evaluation of CD86 gene polymorphism at +1057 position in liver transplant recipients. Transpl Immunol 15 (2005) 69
9. Muro M., Álvarez-López M.R., Torío A., Ontanon J., Minguela A., Marin L., Garcia-Calatayud M.C., Bermejo J., and Garcia-Alonso A.M. HLA-DRB1 and -DQB1 polymorphism in liver recipients: relationship between HLA-DQB1*0302 allele frequency and acute rejection. Hum Immunol 56 (1997) 70
10. Lanier L.L., Gumperz J.E., Parham P., Melero I., López-Botet M., and Phillips J.H. The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol 154 (1995) 3320
11. Moretta A., Biassoni R., Bottino C., Pende D., Viatle M., Puggi A., Mingari M.C., and Moretta A. Major Histocompatibility complex class-I specific receptors on human natural killer and T Lymphocytes. Immunol Rev 155 (1997) 105
12. Mandelboim O., Reyburn H.T., Vales-Gomez M., Pazmany L., Colonna M., Borsellino G., and Strominger J.L. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 184 (1996) 913
13. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 (2005) 201
14. Moya-Quiles M.R., Muro M., Torío A., Sanchez-Bueno F., Miras M., Marin L., Garcia-Alonso A.M., Parrilla P., Dausset J., and Alvarez-Lopez M.R. Human leukocyte antigen-C in short and long-term liver graft acceptance. Liver Transpl 9 (2003) 218
15. Frohn C., Fricke L., Puchta J.C., and Kirchner H. The effect of HLA-C matching on acute renal transplant rejection. Nephrol Dial Transplant 16 (2001) 355
16. Pei J., Akatsuka Y., Anasetti C., Lin M.T., Petersdorf E.W., Hansen J.A., and Martin P.J. Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements. Biol Blood Marrow Transplant 7 (2001) 378
17. Mor E., Solomon H., Gibbs J.F., Colman M.J., Goldstein R.M., Husberg B.S., Gonwa T.A., and Klintmalm G.B. Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome. Semin Liver Dis 12 (1992) 28
18. Anonymous. International Working Party. Terminology for hepatic allograft rejection. Hepatology 22 (1995) 648
19. Anonymous. Banff Schema for grading acute liver allograft rejection: an international consensus document. Hepatology 25 (1997) 658
20. Terasaki P.I., McClelland J.D., Park M.S., and McCurdy B. Microdople assay of human serum cytotoxins. In: Ray J.G., Hare D.B., Pederson P.D., and Kayhoe D.E. (Eds). Manual of tissue typing techniques (1974), Department of Health Education and Welfare Publications, Washington
21. Muro M., Marin L., Torio A., Moya-Quiles M.R., Ontanon J., Minguela A., Alemany J.M., Sanchez-Bueno F., Garcia-Alonso A.M., and Alvarez-Lopez M.R. Effect of HLA matching on liver graft survival. Transplant Proc 31 (1999) 2477
22. Svejgaard A., and Ryder L.P. HLA and disease associations: detecting the strongest association. Tissue Antigens 43 (1994) 18
23. Oertel M., Kohlhaw K., Diepolder H.M., Schroder S., Schwarz R., Tannapfel A., Mossner J., Hauss J., and Berr F. Alloreactivity of natural killer cells in allogenic liver transplantation. Transplantation 72 (2001) 116
24. Bishara A., Brautbar C., Zamir G., Eid A., and Safadi R. Impact of HLA-C and Bw epitopes disparity on liver transplant outcome. Hum Immunol 66 (2005) 1099
25. Falk K., Rotzschke O., Grahovac B., Schendel D., Stevanovic S., Gnau V., Jung G., Strominger J.L., and Rammensee H.G. Allele-specific peptide ligands motifs of HLA-C molecules. Proc Natl Acad Sci USA 90 (1993) 12005
26. Farina C., van der Bruggen P., Boel P., Parmiani G., and Sensi M. Conserved TCR usage by HLA-Cw*1601-restricted T cell clones recognizing melanoma antigens. Int Immunol 8 (1996) 1463
27. Breckpot K., Heirman C., De Greef C., van der Bruggen P., and Thielemans K. Identification of new antigenic peptide presented by HLA-Cw*07 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses. J Immunol 172 (2004) 2232
28. Gussow D., Rein R.S., Meijer I., de Hoog W., Seemann G.H., Hochstenbach F.M., and Ploegh H.L. Isolation, expression and the primary structure of HLA-Cw1 and HLA-Cw2 genes: evolutionary aspects. Immunogenetics 25 (1987) 313
29. Zemmour J., and Parham P. Distinctive polymorphism at the HLA-C locus: Implications for the expression of HLA-C. J Exp Med 176 (1992) 937
30. Gladman D.D., Cheung C., Ng C.M., and Wade J.A. HLA-C locus alleles in patients with psoriatic arthritis (PsA). Hum Immunol 60 (1999) 259
31. Moloney M.M., Thompson L.J., Strettell M.J., Williams R., and Donaldson P.T. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis. Hepatology 28 (1998) 660
32. Strettell M.D., Thomson L.J., Donaldson P.T., Bunce M., O′Neill C.M., and Williams R. HLA-C genes and susceptibility to type 1 autoimmune hepatitis. Hepatology 26 (1997) 1023
33. Biassoni R., Falco M., Cambiaggi A., Costa P., Verdiani S., Pende D., Conte R., Di Donato C., Pahrham P., and Moretta L. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by group 2 or group 1 NK clones. J. Exp Med 182 (1995) 605
34. Shilling H.G., Young N., Guethlein L.A., Cheng N.W., Gardiner C.M., Tyan D., and Parham P. Genetic control of human NK cell repertoires. J Immunol 169 (2002) 239
35. Vivier E., and Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 4 (2004) 190
36. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., Martelli M.F., and Velardi A. Effectiveness of donor natural killer cell alloreactivity in mismatched haematopoietic transplants. Science 295 (2002) 2097
37. De Santis D., Witt C., Nagler A., Brautbar C., Christiansen F., and Bishara A. Compatibility of HLA-C KIR ligands and donor recipients KIR genotypes influence outcome following single haplotype matches stem cells transplantation. Tissue Antigens 59 (2002) 26
38. Shilling H.G., McQueen K.L., Cheng N.W., Shizuru J.A., Negrin R.S., and Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 101 (2003) 3730
39. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., and Parham P. Role of HLA and KIR polymorphisms in natural killler cell repertoire selection and modulation of effector function. J. Exp Med 203 (2006) 633
40. +T cells is controlled by T-cell receptor engagement. Nature 403 (2000) 325
41. Falk C.S., Nöbner E., Frankenberg B., and Schendel D.J. Non-MHC-restricted CD4+ T lymphocytes are regulated by HLA-Cw7-mediated inhibition. Hum Immunol 61 (2000) 1219
42. Guerra N., Michel F., Gati A., Gaudin C., Mishal Z., Escudier B., Acuto O., Chouaib S., and Caignard A. Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction. Blood 100 (2002) 2874